How is ascites managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ascites in Cirrhosis

Start with dietary sodium restriction to 90 mmol/day (5.2 g salt/day) and spironolactone 100 mg daily as monotherapy, escalating to 400 mg/day before adding furosemide up to 160 mg/day if needed. 1, 2

Initial Diagnostic Evaluation

Perform diagnostic paracentesis on all cirrhotic patients with ascites at hospital admission to rule out spontaneous bacterial peritonitis and characterize the fluid. 1, 2 Key analyses include:

  • Serum ascites-albumin gradient (SAAG) in preference to ascitic protein 1, 2
  • Inoculate ascitic fluid into blood culture bottles at bedside and examine for neutrophil count 1, 2
  • Ascitic amylase only when pancreatic disease is suspected 1

First-Line Medical Management

Sodium Restriction

Restrict dietary sodium to 90 mmol/day (5.2 g salt/day) - essentially a "no added salt" diet. 1, 2 Bed rest is not recommended and provides no benefit. 1

Diuretic Therapy Algorithm

For first presentation of moderate ascites:

  • Begin with spironolactone 100 mg once daily as monotherapy 1, 2, 3
  • Increase spironolactone by 100 mg every 7 days up to maximum 400 mg/day if inadequate response 1, 2
  • Only add furosemide 40 mg daily if spironolactone 400 mg fails 1
  • Increase furosemide up to 160 mg/day while maintaining spironolactone 1
  • Maintain spironolactone:furosemide ratio of 100:40 mg to preserve normokalemia 2, 3

For recurrent moderate to severe ascites:

  • Start combination therapy immediately: spironolactone 100 mg plus furosemide 40 mg daily 1, 2, 3
  • Escalate both simultaneously every 3-5 days to maximum doses 1, 2, 3

Monitoring Diuretic Response

Target weight loss of 0.5 kg/day without peripheral edema, or 1 kg/day with edema present. 1, 2, 3 Monitor:

  • Serum electrolytes (sodium, potassium) frequently 1, 2
  • Serum creatinine for azotemia 1
  • Spot urine sodium:potassium ratio to assess diuretic response (target 1.8-2.5) 1, 2

Management of Hyponatremia During Diuretic Therapy

Serum sodium 126-135 mmol/L with normal creatinine:

  • Continue diuretics with close electrolyte monitoring 1
  • Do not restrict water 1

Serum sodium 121-125 mmol/L with normal creatinine:

  • Stop diuretics or adopt cautious approach (international opinion varies, but safer to stop) 1

Serum sodium 121-125 mmol/L with elevated creatinine (>150 μmol/L or >120 μmol/L and rising):

  • Stop diuretics immediately and give volume expansion 1

Serum sodium <120 mmol/L:

  • Stop diuretics and perform volume expansion with colloid (haemaccel, gelofusine, voluven) or saline 1
  • Avoid increasing serum sodium by >12 mmol/L per 24 hours to prevent central pontine myelinolysis 1
  • Fluid restriction to 1-1.5 L/day only for severe hyponatremia (<125 mmol/L), though evidence is limited 1

Management of Large Volume or Tense Ascites

Therapeutic paracentesis is first-line treatment for large or refractory ascites rather than escalating diuretics. 1, 2

For paracentesis <5 liters:

  • Use synthetic plasma expander (150-200 ml gelofusine or haemaccel) 1, 2
  • Albumin not required for smaller volumes 1

For large volume paracentesis (≥5 liters):

  • Administer albumin 8 g per liter of ascites removed (approximately 100 ml of 20% albumin per 3 liters removed) 1, 2
  • Give volume expansion after paracentesis is complete 1
  • Reinstitute diuretics within 1-2 days to prevent reaccumulation 1

Refractory Ascites

Defined as ascites unresponsive to maximum diuretic therapy (spironolactone 400 mg/day plus furosemide 160 mg/day) or rapid recurrence. 4, 5, 6 Treatment options:

  • Serial large volume paracentesis with albumin replacement 1, 4, 5
  • TIPS (transjugular intrahepatic portosystemic shunt) for appropriate candidates requiring frequent paracentesis 1, 5
  • Liver transplantation evaluation - all patients with refractory ascites should be considered 1, 4, 5

Critical Pitfalls to Avoid

Overzealous diuresis causes:

  • Intravascular volume depletion leading to renal impairment (25% of cases) 1
  • Hepatic encephalopathy (26% of cases) 1
  • Hyponatremia (28% of cases) 1

Never use furosemide as monotherapy - it is less effective than spironolactone and should not be used alone. 2, 7

Avoid NSAIDs - they reduce urinary sodium excretion, induce azotemia, and antagonize diuretic effects. 3, 8

Monitor for spironolactone-induced gynecomastia - substitute amiloride 10-40 mg/day if needed, though it is less effective. 2, 3

Ensure compliance with sodium restriction - if urinary sodium exceeds dietary intake despite diuretic resistance, assume non-compliance before declaring refractoriness. 1

Liver Transplantation Considerations

Development of ascites is an indication for transplantation evaluation as it marks hepatic decompensation and significantly worsens prognosis. 1, 4, 5, 9 Treatment of ascites improves quality of life and prevents complications like spontaneous bacterial peritonitis, but does not improve survival - only transplantation does. 1, 5, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Ascites in Cirrhotic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Ascites in Non-Alcoholic Cirrhosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.

Liver international : official journal of the International Association for the Study of the Liver, 2010

Research

Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.

Acta gastro-enterologica Belgica, 1990

Guideline

Management of Malignant Ascites in the ICU

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ascites: pathogenesis and therapeutic principles.

Scandinavian journal of gastroenterology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.